Evidence map›Paper›PMID 29504210›Full record

ArticlePlant biotechnology journal2018

Trans-species synthetic gene design allows resistance pyramiding and broad-spectrum engineering of virus resistance in plants.

Anna Bastet, Baptiste Lederer, Nathalie Giovinazzo, Xavier Arnoux, Sylvie German-Retana, Catherine Reinbold, Véronique Brault, Damien Garcia, Samia Djennane, Sophie Gersch and 3 more

Open access · goldAbstract read
In one paragraph

Article in Plant biotechnology journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
12.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Role of the Genetic Background in Resistance to Plant Viruses.International journal of molecular sciences · 2018
    Pooled it
  2. Article
  3. Review
  4. Article
  5. EditingInternational journal of molecular sciences · 2024
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Anna BastetGAFL, INRA, Montfavet, France.
Baptiste LedererGAFL, INRA, Montfavet, France.
Nathalie GiovinazzoGAFL, INRA, Montfavet, France.
Xavier ArnouxUMR 1332 Biologie du Fruit et Pathologie, INRA, Univ. Bordeaux, Villenave d'Ornon, France.
Sylvie German-RetanaUMR 1332 Biologie du Fruit et Pathologie, INRA, Univ. Bordeaux, Villenave d'Ornon, France.
Catherine ReinboldUniversité de Strasbourg, INRA, UMR-A 1131, Santé de la Vigne et Qualité du Vin, Colmar, France.
Véronique BraultUniversité de Strasbourg, INRA, UMR-A 1131, Santé de la Vigne et Qualité du Vin, Colmar, France.
Damien GarciaCentre National de la Recherche Scientifique, Institut de Biologie Moléculaire des Plantes (IBMP), UPR 2357, Strasbourg, France.
Samia DjennaneUniversité de Strasbourg, INRA, UMR-A 1131, Santé de la Vigne et Qualité du Vin, Colmar, France.
Sophie GerschUniversité de Strasbourg, INRA, UMR-A 1131, Santé de la Vigne et Qualité du Vin, Colmar, France.
Olivier LemaireUniversité de Strasbourg, INRA, UMR-A 1131, Santé de la Vigne et Qualité du Vin, Colmar, France.
Christophe RobagliaAix Marseille University, UMR 7265 Biologie Végétale et Microbiologie Environnementales, Laboratoire de Génétique et Biophysique des Plantes, Marseille, France.
Jean-Luc GalloisGAFL, INRA, Montfavet, France.ORCID http://orcid.org/0000-0003-0451-1740
Université de Strasbourg · FRGénétique et amélioration des fruits et légumes · FRCentre National de la Recherche Scientifique · FRUniversité de Bordeaux · FRInstitut de Biologie Moléculaire des Plantes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To infect plants, viruses rely heavily on their host's machinery. Plant genetic resistances based on host factor modifications can be found among existing natural variability and are widely used for some but not all crops. While biotechnology can supply for the lack of natural resistance alleles, new strategies need to be developed to increase resistance spectra and durability without impairing plant development. Here, we assess how the targeted allele modification of the Arabidopsis thaliana translation initiation factor eIF4E1 can lead to broad and efficient resistance to the major group of potyviruses. A synthetic Arabidopsis thaliana eIF4E1 allele was designed by introducing multiple amino acid changes associated with resistance to potyvirus in naturally occurring Pisum sativum alleles. This new allele encodes a functional protein while maintaining plant resistance to a potyvirus isolate that usually hijacks eIF4E1. Due to its biological functionality, this synthetic allele allows, at no developmental cost, the pyramiding of resistances to potyviruses that selectively use the two major translation initiation factors, eIF4E1 or its isoform eIFiso4E. Moreover, this combination extends the resistance spectrum to potyvirus isolates for which no efficient resistance has so far been found, including resistance-breaking isolates and an unrelated virus belonging to the Luteoviridae family. This study is a proof-of-concept for the efficiency of gene engineering combined with knowledge of natural variation to generate trans-species virus resistance at no developmental cost to the plant. This has implications for breeding of crops with broad-spectrum and high durability resistance using recent genome editing techniques.

Indexed as

Arabidopsis thalianaeIF4Epotyvirusresistancesynthetic alleletranslational research

Identifiers

PMID29504210
PMCPMC6097130
OpenAlexW2791639687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.